Global Dermal Fillers Market Forecasted To Have Exponential Growth By 2026 End

  • 06 Jun 2019

Global dermal fillers market is projected to value over US$ 8 billion by the end of 2026 and expand at a CAGR of over 8.1% during the forecast period of 2019-2026. 
Dermal fillers are certain specific fillers made for soft tissues which are injected into the top layer of skin. This is done in order to enhance the surface of the skin and make the appearance smoother. It also involves the reduction of wrinkles and eliminating the signs of aging. These fillers are ideal solutions to tweak skin through viable options of plumping cheeks and lips to make them look fuller, filling and fine-tuning creases and lines, and augmenting facial contours.
The global market of dermal fillers is projected to expand at a reasonable CAGR during the forecast period.  Market growth can be contributed to a lot of factors. The growing interest in anti-ageing as well as considerable private equity investments, rising urge to imitate celebrities thus fueling the lip-cheek enhancement procedures, help widen the market reach.  The improvements in technology have creases the life of these synthetic implants and refined the material and volume of the same thus widening the pool of customers. New innovations and upgrades in the industry are that of creating fillers with lower mass and increased consistency thus resulting in the fabrication of superior substances in terms of their lifetime and sustainability. For self-enhancement purposes along with the fascination of physical appearances, the people have fair disposable income which comes hand in hand with the facial aesthetics awareness drive this market over and fund this market beyond the predicted time frame. 
The sagging of skin is usually experienced during old age and thus the rising geriatric population should aid the escalating market of these fillers. the luxuries of medical spas and rejuvenation centres lucratively bring business to this industry. 

Global Dermal Fillers Market; Restraints
> Lack of specially skilled dermatologists 
> Lack of regulations governing the quality of products
> Emergence of substitutes and counterfeit products 
> Serious health complications in the long run

Global Dermal Fillers Market Segmentation 
By Filler Type
> Calcium hydroxylapatite
> Hyaluronic acid
> Polyalkylimide
> Polylactic acid, 
> Polymethylmethacrylate microspheres (PMMA)
Hyaluronic acid enjoyed major market share as a segment in 2017. It is expected to further expand during the forecast period. Various applications Technological improvements in the development of newer HA dermal fillers may further help the market. The numerous approved products with a lower risk of complications lead to growing acceptance help accelerate growth during the forecast period. 

By End-User
> Hospital
> Cosmetic Clinics
> Outpatient Centres
> Beauty Centres
> Academics
The hospital segment did dominate the market in 2017 and is further anticipated to garner maximum revenue during the forecast period as well. Cosmetic clinics, although held the major market share of around 57% in 2017 and is likely to soar at the highest CAGR during the forecast period.  Constant growth of innovative products and new treatments offered by cosmetics clinics should stimulate the segment’s growth.

By Region:  
> Europe  
> North America  
> APAC  
> Latin America
> Rest of World 
North America and Europe, together, dominated the global market share in 2017. While North America enjoyed a major market share in 2017, is to rise further during the forecast period. The expansion of the market here is majorly attributed to U.S. On the other hand, the markets in Asia Pacific are projected to rise at a high CAGR during the forecast period due to the ever-growing markets in Japan and India.

Competitive Landscape:  
> Tier 1 players- Established companies in the market with a major market share  
> Tier 2 players - Emerging players which are growing rapidly 
> New Entrants  
Major shareholders in the global dermal fillers market are  Allergan plc, Sinclair Pharma (a subsidiary of Huadong Medicine Ltd), Merz Pharma GmbH & Co. KGaA, Nestle Skin Health (Galderma), BioPlus Co., Ltd., Bioxis pharmaceuticals, SCULPT Luxury Dermal Fillers LTD, Dr. Korman Laboratories Ltd., Prollenium Medical Technologies, Advanced Aesthetic Technologies, Inc., and TEOXANE Laboratories 

FutureWise Takeaways  
> Growth prospects  
> SWOT analysis 
> Key trends 
> Key data-points affecting market growth  

Objectives of the Study:
> To provide with an exhaustive analysis on the global dermal filler market on the basis of filler type, end-user and region   
> To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) 
> To evaluate and forecast micro-markets and an overall market  
> To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East 
> To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
> Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact